Technetium Tc 99m Aggregated Albumin
Showing 1 - 25 of 1,862
Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)
Active, not recruiting
- Metastatic Liver Carcinoma
- +3 more
- Angiography
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell
Active, not recruiting
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
- +2 more
- Computed Tomography
- +7 more
-
Seattle, Washington
- +1 more
Jul 18, 2022
Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Recruiting
- Hepatocellular Carcinoma
- Technetium-99m macroaggregated albumin (Tc-99m MAA)
-
Chicago, IllinoisNorthwestern University
Jan 17, 2023
Carcinoma, Carcinoma, Hepatocellular, Liver Tumor Trial in Spokane (99mTc-Macro Albumin Aggregate)
Recruiting
- Carcinoma
- +2 more
- 99mTc-Macro Albumin Aggregate
-
Spokane, WashingtonInland Imaging
May 4, 2023
Prostate Cancer Trial in Tomsk (Whole body study and SPECT with [99mTc]Tc-BQ0413)
Enrolling by invitation
- Prostate Cancer
- Whole body study and SPECT with [99mTc]Tc-BQ0413
-
Tomsk, Russian FederationTomskNRMC
Oct 26, 2023
Prostate Cancer, Breast Cancer Trial in Tomsk (Intravenous injection of [99mTc]Tc-DB8)
Recruiting
- Prostate Cancer
- Breast Cancer
- Intravenous injection of [99mTc]Tc-DB8
-
Tomsk, Russian FederationTomskNRMC
Jul 4, 2023
Ovarian Epithelial Cancer Trial (99mTC nanocolloid albumin injection, ICG injection)
Not yet recruiting
- Ovarian Epithelial Cancer
- 99mTC nanocolloid albumin injection
- ICG injection
- (no location specified)
Jul 6, 2023
Hemoptysis, Malignant Tumor, Lung Cancer Trial (Technicium 99 MAA infusion)
Withdrawn
- Hemoptysis
- +2 more
- Technicium 99 MAA infusion
- (no location specified)
Aug 15, 2022
Breast Tumor Trial in Rochester (procedure, other, radiation)
Recruiting
- Breast Neoplasm
- Biopsy of Breast
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 22, 2023
Primary Malignant Liver Tumor Trial in Palo Alto (procedure, device, diagnostic test)
Completed
- Primary Malignant Liver Neoplasm
- Computed Tomography (CT)
- +4 more
-
Palo Alto, CaliforniaStanford University
Dec 8, 2021
Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)
Enrolling by invitation
- Breast Cancer Female
-
Tomsk, Russian FederationOlga
Jun 19, 2023
Amyloidosis, Transthyretin Amyloid Cardiomyopathy Trial in Portland (99m-technetium pyrophosphate scintigraphy)
Recruiting
- Amyloidosis
- Transthyretin Amyloid Cardiomyopathy
- 99m-technetium pyrophosphate scintigraphy
-
Portland, OregonOregon Health & Science University
Feb 17, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Radium-223
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 20, 2023
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IV Liver Cancer Trial in Seattle (Computed Tomography, Single
Recruiting
- Hepatocellular Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Seattle, Washington
- +1 more
Feb 24, 2022
Primary Ciliary Dyskinesia Trial in Chapel Hill (Albuterol, Technetium99m - Sulfur Colloid (Tc99m-SC))
Recruiting
- Primary Ciliary Dyskinesia
- Albuterol
- Technetium99m - Sulfur Colloid (Tc99m-SC)
-
Chapel Hill, North CarolinaUniversity of North Carolina Chapel Hill
Aug 10, 2022
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,
Active, not recruiting
- Estrogen Receptor Negative
- +3 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Houston, Texas
- +5 more
Feb 11, 2022
Eyelid Sebaceous Gland Carcinoma Trial in Houston (Lymph Node Mapping, Sentinel Lymph Node Biopsy, Technetium Tc-99m Sulfur
Recruiting
- Eyelid Sebaceous Gland Carcinoma
- Lymph Node Mapping
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2021
Lung Cancer Trial in Boston (Tc99m-MAA)
Recruiting
- Lung Cancer
- Tc99m-MAA
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Sep 10, 2021
Endometrial Cancer Trial in Stanford (Lymphoseek, Single Photon Emission Computed Tomography (SPECT), Indocyanine Green (ICG))
Suspended
- Endometrial Cancer
- Lymphoseek
- +3 more
-
Stanford, CaliforniaStanford University, School of Medicine
Jun 13, 2022
Eosinophilic Esophagitis Trial in Salt Lake City (radiation, drug, procedure)
Completed
- Eosinophilic Esophagitis
- Computerized Tomography scan
- +4 more
-
Salt Lake City, UtahUniversity of Utah
Apr 29, 2021
Head and Neck Squamous Cell Carcinoma Trial in Palo Alto (Panitumumab-IRDye800, Lymphoseek)
Suspended
- Head and Neck Squamous Cell Carcinoma
-
Palo Alto, CaliforniaStanford University, School of Medicine
Aug 16, 2021
Liver Metastases, Colorectal Carcinoma Trial in Birmingham (Tilmanocept (Technetium Tc 99m tilmanocept Injection), SPECT/CT
Terminated
- Liver Metastases
- Colorectal Carcinoma
- Tilmanocept (Technetium Tc 99m tilmanocept Injection)
- SPECT/CT Imaging
-
Birmingham, AlabamaUniversity of Alabama Birmingham
Sep 8, 2020
Breast Cancer Trial in Shanghai (Injection of 99mTc-NM-02)
Unknown status
- Breast Cancer
- Injection of 99mTc-NM-02
-
Shanghai, Shanghai, ChinaShanghai General Hospital
Dec 6, 2020
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023